Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02963506
Brief Title: A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis (BE AGILE)

First Submitted : November 10, 2016
First Submitted that Met QC Criteria : November 14, 2016
First Posted : November 15, 2016 (Estimate)

Results First Submitted : October 21, 2020
Results First Submitted that Met QC Criteria : October 21, 2020
Results First Posted : November 16, 2020

Certification/Extension First Submitted : October 22, 2018
Certification/Extension First Submitted that Met QC Criteria : October 22, 2018
Certification/Extension First Posted : October 23, 2018

Last Update Submitted that Met QC Criteria : November 26, 2020
Last Update Posted : December 17, 2020